Tivic Health Systems, Inc.(TIVC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TIVC Tivic Health Systems, Inc.

Post-Market Trading 11-21 19:39:59 EST

0.2422

-0.0067

-2.69%

盘后0.2410

-0.0012-0.50%

19:36 EST

High0.2599	Low0.2415	Vol507.17K
Open0.2550	D1 Closing0.2489	Amplitude7.39%
Mkt Cap2.00M	Tradable Cap1.96M	Total Shares8.27M
T/O125.60K	T/O Rate6.28%	Tradable Shares8.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TIVC","market":"US","secType":"STK","nameCN":"Tivic Health Systems, Inc.","latestPrice":0.2422,"timestamp":1732222800000,"preClose":0.2489,"halted":0,"volume":507168,"hourTrading":{"tag":"盘后","latestPrice":0.241,"preClose":0.2422,"latestTime":"19:36 EST","volume":6243,"amount":1529.38572987,"timestamp":1732235813855},"delay":0,"floatShares":8080300,"shares":8266085,"eps":-1.950589,"marketStatus":"Post-Market Trading","change":-0.0067,"latestTime":"11-21 19:39:59 EST","open":0.255,"high":0.2599,"low":0.2415,"amount":125598.30910848001,"amplitude":0.073925,"askPrice":0.2491,"askSize":15,"bidPrice":0.2401,"bidSize":1800,"shortable":3,"etf":0,"ttmEps":-1.950589,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1732237200000},"marketStatusCode":4,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":0.2489,"preHourTrading":{"tag":"盘前","latestPrice":0.2503,"preClose":0.2489,"latestTime":"09:28 EST","volume":4448,"amount":1118.9322080000002,"timestamp":1732199301204},"postHourTrading":{"tag":"盘后","latestPrice":0.241,"preClose":0.2422,"latestTime":"19:36 EST","volume":6243,"amount":1529.38572987,"timestamp":1732235813855},"volumeRatio":0.155466},"requestUrl":"/m/hq/s/TIVC","defaultTab":"news","newsList":[{"id":"2484636419","title":"Tivic Health Systems Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$1.48 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2484636419","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484636419?lang=en_us&edition=fundamental","pubTime":"2024-11-17 22:22","pubTimestamp":1731853377,"startTime":"0","endTime":"0","summary":"NasdaqCM:TIVC Earnings and Revenue History November 17th 2024. All figures shown in the chart above are for the trailing 12 month  period. Tivic Health Systems shares are down 29% from a week ago.You still need to take note of risks, for example - Tivic Health Systems has   6 warning signs   we think you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tivic-health-systems-third-quarter-142257361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TIVC"],"gpt_icon":0},{"id":"2483394181","title":"BRIEF-Tivic Health Systems Q3 Net Income USD -1.431 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483394181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483394181?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:36","pubTimestamp":1731645405,"startTime":"0","endTime":"0","summary":"BRIEF-Tivic Health Systems Q3 Net Income USD -1.431 Million\n\n\nNov 15 (Reuters) - Tivic Health Systems Q3 revenue USD 126 thousand.\n\nQ3 operating expenses USD 1.475 million\nQ3 operating income USD -1.431 million\nQ3 gross profit USD 44 thousand\nQ3 basic EPS USD -0.23","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nPLXCA342D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIVC","BK4082"],"gpt_icon":0},{"id":"2483394909","title":"Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483394909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483394909?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:36","pubTimestamp":1731645362,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA2C68G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TIVC","BK4082"],"gpt_icon":0},{"id":"2483902394","title":"Tivic Health Systems Q3 Gross Profit USD 44 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2483902394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483902394?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:36","pubTimestamp":1731645360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nPLXCA342D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","TIVC"],"gpt_icon":0},{"id":"2483392354","title":"Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2483392354","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483392354?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:36","pubTimestamp":1731645360,"startTime":"0","endTime":"0","summary":"Pre-recorded Conference Call to Follow at 1:30 p.m. PDT/4:30 p.m EDT. FREMONT, Calif., November 15, 2024----Tivic Health Systems, Inc. , a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended September, 30, 2024 financial results and discussed growth strategies based on its novel, patent-pending vagus nerve stimulation  science and device technology.\"This quarter we made significant progress on each of the three prongs of our strategy for delivering shareholder value,\" stated Jennifer Ernst, CEO of Tivic Health. \"The first prong is the aggressive steps we have taken to improve the economics of the ClearUP product line -- our commercially available handheld, trigeminal nerve stimulation device for sinus and allergy conditions. This quarter, we completed the redesign of our supply chain, and, net of one-time costs, saw upwards of 70% gross margin in the months following the transition.Third Quarter and Subsequent","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zMVQl.5xeoCL5RSx4eSReg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/32e4d278969ba38ac862af1b044c6cbc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zMVQl.5xeoCL5RSx4eSReg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/32e4d278969ba38ac862af1b044c6cbc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tivic-reports-third-quarter-2024-043600084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FSI","BK4082","TIVC","BK4109"],"gpt_icon":0},{"id":"2483539174","title":"Tivic Health Systems Reports Third Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483539174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483539174?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:20","pubTimestamp":1731644449,"startTime":"0","endTime":"0","summary":"Tivic Health Systems, Inc. ( ($TIVC) ) has released its Q3 earnings. Here is a breakdown of the information Tivic Health Systems, Inc. presented to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tivic-health-systems-reports-third-quarter-2024-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tivic-health-systems-reports-third-quarter-2024-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","TIVC"],"gpt_icon":0},{"id":"2483358011","title":"Tivic Health Systems Advances in Bioelectronic Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358011","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358011?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:32","pubTimestamp":1731619979,"startTime":"0","endTime":"0","summary":"Tivic Health Systems ( ($TIVC) ) just unveiled an update. Tivic Health Systems reported its third quarter 2024 financial results, highlighting sign...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tivic-health-systems-advances-in-bioelectronic-medicine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tivic-health-systems-advances-in-bioelectronic-medicine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","TIVC"],"gpt_icon":0},{"id":"2483217330","title":"Tivic Health Systems Q3 EPS $(0.23) Up From $(1.48) YoY, Sales $126.00K Down From $282.00K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2483217330","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483217330?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:22","pubTimestamp":1731619322,"startTime":"0","endTime":"0","summary":"Tivic Health Systems (NASDAQ:TIVC) reported quarterly losses of $(0.23) per share. This is a 84.46 percent increase over losses of $(1.48) per share from the same period last year.  The company reported $126.00 thousand","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41990353/tivic-health-systems-q3-eps-0-23-up-from-1-48-yoy-sales-126-00k-down-from-282-00k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tivic Health Systems Q3 EPS $(0.23) Up From $(1.48) YoY, Sales $126.00K Down From $282.00K YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIVC"],"gpt_icon":0},{"id":"2483806287","title":"Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806287","media":"Business Wire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483806287?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:45","pubTimestamp":1731591900,"startTime":"0","endTime":"0","summary":"FREMONT, Calif., November 14, 2024----Tivic Health Systems, Inc. , a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been completed in the optimization study for Tivic Health’s patent pending, non-invasive vagus nerve stimulation  device.\"While implanted VNS technologies have proven their clinical efficacy and commercial viability, they are not always appropriate for certain clinical scenarios,\" stated Jennifer Ernst, CEO of Tivic Health Systems. \"Early non-invasive VNS approaches have resulted in variable responses and modest efficacy. In contrast, we anticipate this study will allow us to optimize our novel approach to treating diseases with unmet needs and capitalize on the gap between invasive and non-invasive VNS treatments,\" concluded Ernst.Tivic previously announced it has engaged Fletcher Spaght, Inc. , a leading healthcare growth strategy firm, to accelerate its product development and commercial strategy. FSI","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/2ojhib54M_XS90bFQ4FrFQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/685fc4ab95ab643624f734c35a9480de","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/2ojhib54M_XS90bFQ4FrFQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/685fc4ab95ab643624f734c35a9480de"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enrollment-complete-tivic-health-optimization-134500403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FSI","BK4109","TIVC"],"gpt_icon":0},{"id":"2482702008","title":"Tivic Health Validates European Patents in Great Britain, Germany, and France","url":"https://stock-news.laohu8.com/highlight/detail?id=2482702008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482702008?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:30","pubTimestamp":1731418258,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nFWN3MJ0TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TIVC","BK4082"],"gpt_icon":0},{"id":"2482668707","title":"Tivic Health Validates European Patents in Great Britain, Germany, and France","url":"https://stock-news.laohu8.com/highlight/detail?id=2482668707","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482668707?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:30","pubTimestamp":1731418200,"startTime":"0","endTime":"0","summary":"Patents cover methods used to identify key treatment points and dynamically personalize simulation. FREMONT, Calif., November 12, 2024----Tivic Health Systems, Inc. , a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validated two granted European Patent Office  patents in Great Britain, Germany, and France. The Company believes these validations are an important step toward securing the foundation for an international market position.European Patent EP3615133, both titled \"Adaptive Trigger For a Microcurrent Stimulation Device\" protects device and methods that the company uses to identify preferred treatment points and trigger the treatment mode of its sinus treatment device. Triggers can be programmed in various ways to improve consumer performance and ease of use.European Patent EP3615134 entitled \"Sinus Treatment Device With Adaptive Circuit\" protects the device and methods that the company uses to dynamically adjust s","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Zu.xrYqFjnXql6L93b9nqA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f19eaaf095512c697879d7b1ad081791","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Zu.xrYqFjnXql6L93b9nqA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f19eaaf095512c697879d7b1ad081791"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tivic-health-validates-european-patents-133000087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TIVC"],"gpt_icon":0},{"id":"2481944907","title":"Press Release: Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2481944907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481944907?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:33","pubTimestamp":1730986380,"startTime":"0","endTime":"0","summary":"-- Conference Call and Webcast to Follow at 1:30 p.m. PST/4:30 p.m. EST -. Tivic Health Systems, Inc. , a health tech company that develops and commercializes bioelectronic medicine, today announced it will report financial results on Thursday, November 14 after market close. The release will be followed by a pre-recorded conference call and webcast at 1:30 p.m. PST / 4:30 p.m. EST. Shareholders, interested parties, and prospective investors are invited to join via dial in or webcast. The company invites questions to be submitted to ir@tivichealth.com by November 11.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","TIVC","BK4232"],"gpt_icon":0},{"id":"2479284748","title":"Tivic Health Systems Enrolls First Subject in Optimization Study for Vagus Nerve Stimulation Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2479284748","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479284748?lang=en_us&edition=fundamental","pubTime":"2024-10-29 22:54","pubTimestamp":1730213693,"startTime":"0","endTime":"0","summary":"Tivic Health Systems  said Tuesday it has enrolled a first subject in the optimization study for its patent-pending non-invasive vagus nerve stimulation device.Conducted by The Feinstein Institute of Bioelectronic Medicine, the study aims to determine the optimal device settings, such as frequency and treatment duration for influencing autonomic nervous system function, the company said, adding that the enrollment is anticipated to be completed by early December.Shares of Tivic Health Systems were up 1.7% in recent Tuesday trading.Price: 0.30, Change: +0.01, Percent Change: +1.69","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","TIVC"],"gpt_icon":0},{"id":"2479018274","title":"First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2479018274","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479018274?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:00","pubTimestamp":1730203200,"startTime":"0","endTime":"0","summary":"FREMONT, Calif., October 29, 2024----Tivic Health Systems, Inc. , a health tech company developing and commercializing bioelectronic medicine, announced today that the first study subject has been enrolled in the optimization study for Tivic Health’s patent pending, non-invasive vagus nerve stimulation device.The study, being run by The Feinstein Institute of Bioelectronic Medicine, will identify device parameters, including frequency and duration of treatment, that optimally influence autonomic nervous system  function. The results will be used to inform clinical indication priority and commercial development. Enrollment is expected to be complete by early December.Tivic previously announced it has engaged Fletcher Spaght, Inc. , a leading healthcare growth strategy firm, to accelerate its product development and commercial strategy. FSI has conducted a comprehensive market assessment of Tivic Health’s ncVNS technology drawing from clinical outcomes from Tivic Health’s successful Phas","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ASNoc3tmG1BJnngl1cH7mw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/49de5aecd6564d53066d6b2d4b6140bf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ASNoc3tmG1BJnngl1cH7mw--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/49de5aecd6564d53066d6b2d4b6140bf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/first-subject-enrolled-tivic-health-120000582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","TIVC","FSI"],"gpt_icon":0},{"id":"2477338486","title":"Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477338486","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477338486?lang=en_us&edition=fundamental","pubTime":"2024-10-24 20:30","pubTimestamp":1729773000,"startTime":"0","endTime":"0","summary":"- Presentation will highlight Tivic Health’s recent advancements in vagus nerve stimulation -. SAN FRANCISCO, October 24, 2024----Tivic Health Systems, Inc. , a health tech company developing and commercializing bioelectronic medicine, announced today that CEO Jennifer Ernst will presenting at the upcoming BioFuture 2024 Conference in New York, October 28-30. Ms. Ernst’s presentation, Tuesday, October 29 at 2:30 p.m. EDT, will focus on the company’s advances in bioelectronic medicine, including its recently released data on a new approach to vagus nerve stimulation.This press release may contain \"forward-looking statements\" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Fo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/lrFXs_0NQmp.2s9Fz2070w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/da849088aac2322d43ed7c61d21349cf","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/lrFXs_0NQmp.2s9Fz2070w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/da849088aac2322d43ed7c61d21349cf"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tivic-health-ceo-jennifer-ernst-123000580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TIVC","BK4082"],"gpt_icon":1},{"id":"2468587766","title":"Tivic Health Gets Institutional Review Board's Approval for ncVNS Optimization Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2468587766","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468587766?lang=en_us&edition=fundamental","pubTime":"2024-09-18 22:33","pubTimestamp":1726670011,"startTime":"0","endTime":"0","summary":"Tivic Health Systems  said Wednesday it has received approval from The Feinstein Institutes' Institutional Review Board for the next phase of clinical work on its non-invasive cervical vagus nerve stimulation technology.The clinical research collaboration with Feinstein is designed to advance the development of its ncVNS technology by refining and optimizing stimulation parameters, the company said.Insights from the study will guide the selection of clinical populations and help shape the design of future clinical trials, with key goals of the current study including optimizing treatment strategies and accelerating product development, the firm said.Tivic also said it partnered with Fletcher Spaght, a healthcare growth strategy firm, to explore potential clinical applications of its ncVNS system that address high unmet medical needs.\"We are taking an integrated approach to clinical, product development and go-to-market planning for our medical-grade non-invasive VNS program,\" said Chie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TIVC","BK4082"],"gpt_icon":0},{"id":"2468861155","title":"Tivic Health Receives Approval From Institutional Review Board for Ncvns Optimization Study, Readies for Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2468861155","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468861155?lang=en_us&edition=fundamental","pubTime":"2024-09-18 21:00","pubTimestamp":1726664402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240918:nTUA9NBD2J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TIVC","BK4082"],"gpt_icon":0},{"id":"2468366102","title":"Tivic Health Collaborates With Fletcher Spaght to Develop Strategy for Cervical Vagus Nerve Stimulation Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2468366102","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468366102?lang=en_us&edition=fundamental","pubTime":"2024-09-17 23:37","pubTimestamp":1726587447,"startTime":"0","endTime":"0","summary":"Tivic Health Systems  said Tuesday it has collaborated with Fletcher Spaght to further develop its commercial strategy for non-invasive cervical vagus nerve stimulation, or ncVNS.Fletcher Spaght initially determined about 30 potential medical use cases for Tivic's ncVNS technology as it started a thorough market study of the technology using data from the health tech company's phase 1 trial.Fletcher Spaght is working with Tivic's experts to find the best market entry point by talking to key doctors, patients and insurance providers, Tivic said.Financial details of the collaboration weren't provided.Shares of Tivic fell 3.4% in recent trading.Price: 0.27, Change: -0.01, Percent Change: -3.40","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","TIVC"],"gpt_icon":0},{"id":"2468357609","title":"Tivic Health Accelerates VNS Commercial Strategy Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2468357609","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468357609?lang=en_us&edition=fundamental","pubTime":"2024-09-17 21:00","pubTimestamp":1726578000,"startTime":"0","endTime":"0","summary":"Partners with leading growth strategy firm, Fletcher Spaght. SAN FRANCISCO, September 17, 2024----Tivic Health Systems, Inc. , a health tech company that develops and commercializes bioelectronic medicine, today announced it has partnered with Fletcher Spaght , a leading healthcare growth strategy firm, to accelerate development of its commercial strategy for non-invasive cervical vagus nerve stimulation .FSI Partner, Bill Sigona, stated, \"FSI excels at projects like this, where our insights help clients like Tivic grow while improving patient healthcare. Bringing innovative technologies like ncVNS to market drives us, and we're excited to support Tivic's journey in advancing care across multiple therapeutic areas.\". Tivic Health is a commercial health tech company advancing the field of bioelectronic medicine. Tivic Health’s technology platforms leverage stimulation of the trigeminal, sympathetic, and vagus nerve structures. Tivic Health’s non-invasive and targeted approach to the tre","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/h8UIX87IbOODwUo43OvhqA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6ee5670131b3baf2c7ebea9bc600a452","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/h8UIX87IbOODwUo43OvhqA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6ee5670131b3baf2c7ebea9bc600a452"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tivic-health-accelerates-vns-commercial-130000679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FSI","TIVC","BK4109"],"gpt_icon":0},{"id":"2467080726","title":"BRIEF-Tivic Health Appoints Lisa Wolf As Interim Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2467080726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467080726?lang=en_us&edition=fundamental","pubTime":"2024-09-14 06:24","pubTimestamp":1726266254,"startTime":"0","endTime":"0","summary":"Tivic Health Systems Inc   :   * TIVIC HEALTH APPOINTS LISA WOLF AS INTERIM CHIEF FINANCIAL OFFICERSource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TIVC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tivichealth.com","stockEarnings":[{"period":"1week","weight":-0.248},{"period":"1month","weight":-0.1979},{"period":"3month","weight":-0.2786},{"period":"6month","weight":-0.3853},{"period":"1year","weight":-0.8913},{"period":"ytd","weight":-0.8617}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.186248},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.205132},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.103759},{"month":4,"riseRate":0,"avgChangeRate":-0.09844},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.238703},{"month":6,"riseRate":0.333333,"avgChangeRate":0.025195},{"month":7,"riseRate":0.666667,"avgChangeRate":0.013293},{"month":8,"riseRate":0,"avgChangeRate":-0.352142},{"month":9,"riseRate":0,"avgChangeRate":-0.25932},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.003459},{"month":11,"riseRate":0.333333,"avgChangeRate":0.133144},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.198615}],"exchange":"NASDAQ","name":"Tivic Health Systems, Inc.","nameEN":"Tivic Health Systems, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tivic Health Systems, Inc.(TIVC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tivic Health Systems, Inc.(TIVC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tivic Health Systems, Inc.,TIVC,Tivic Health Systems, Inc.股票,Tivic Health Systems, Inc.股票老虎,Tivic Health Systems, Inc.股票老虎国际,Tivic Health Systems, Inc.行情,Tivic Health Systems, Inc.股票行情,Tivic Health Systems, Inc.股价,Tivic Health Systems, Inc.股市,Tivic Health Systems, Inc.股票价格,Tivic Health Systems, Inc.股票交易,Tivic Health Systems, Inc.股票购买,Tivic Health Systems, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tivic Health Systems, Inc.(TIVC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tivic Health Systems, Inc.(TIVC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}